WSU Researcher's Model Will Target Causes Of Everyday MS SymptomsMost research on multiple sclerosis focuses on the disease's infrequent-but-debilitating consequences. Now, a Wayne State University researcher is targeting MS's more annoying everyday symptoms like difficulty hearing or remembering things.
Adeona Starts Phase II Trials Of New MS DrugAdeona Pharmaceuticals Inc. (NYSE Amex: AEN) said Thursday that it had started a Phase II clinical trial of Trimesta (oral estriol) for the treatment of cognitive dysfunction in multiple sclerosis in women.

More From CBS Detroit

Hump Day Drinks: 8 Cheery Cocktail RecipesNow that you've made it through half the work week, it's time to celebrate!
Daily J

Watch & Listen